Crossmark

Eculizumab therapy in adults with allogeneic hematopoietic cell transplant-associated thrombotic microangiopathy

Published Online: 2016-04-11

Published Print: 2016-09

Authors

Vasu, S

Wu, H

Satoskar, A

Puto, M

Roddy, J

Blum, W

Klisovic, R

Andritsos, L

Hofmeister, C

Benson, D M

Efebera, Y

Jaglowski, S

Penza, S

Cohen, D

Devine, S

Cataland, S
License Information

Text and Data Mining valid from 2016-04-11

Version of Record valid from 2016-04-11
More Information

Article History

First Online: 11 April 2016

Competing interests

: SC has received research funding and honoraria from Alexion, Inc., the manufacturer of eculizumab. The remaining authors declare no conflict of interest.

Document is current